GGrantIndex
Sort

40,608 grants matching prostate cancer

Epithelial Stem Cell Programs

$377,561
Frank D. McKeon · Harvard Medical School · R01 · FY2010 · GM

Endothelin mechanisms in metastic prostate cancer pain

$377,543
Gary R Strichartz · Brigham And Women'S Hospital · R56 · FY2009 · CA

Novobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers

$377,516
Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Urinary biomarkers for prostate cancer diagnosis and risk assessment

$377,500
Wen-Yee Lee · University Of Texas El Paso · SC1 · FY2023 · CA

Novel Nanotechnology Platform for Breast Cancer Treatment

$377,500
Emmanuel O Akala · Howard University · SC1 · FY2016 · CA

Urinary biomarkers for prostate cancer diagnosis and risk assessment

$377,500
Wen-Yee Lee · University Of Texas El Paso · SC1 · FY2022 · CA

THE ROLE OF CENTRAL METABOLISM IN PROSTATE CANCER PROGRESSION

$377,500
Trustees Of Indiana University · · FY2008 · Department of Defense

Urinary biomarkers for prostate cancer diagnosis and risk assessment

$377,500
Wen-Yee Lee · University Of Texas El Paso · SC1 · FY2020 · CA

Novel Nanotechnology Platform for Breast Cancer Treatment

$377,500
Emmanuel O Akala · Howard University · SC1 · FY2015 · CA

Exploring persistent epigenetic changes after prenatal famine exposure in humans

$377,477
L H Lumey · Columbia University Health Sciences · RC1 · FY2010 · HD

HEME Protein Reductases

$377,451
Stephen G. Sligar · University Of Illinois At Urbana-Champaign · R01 · FY2011 · GM

Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function

$377,438
Earl Howard Harrison · Ohio State University · R01 · FY2012 · HL

Utilizing islet autoantibody signatures for precision medicine in type 2 diabetes

$377,436
Nisa M Maruthur · Johns Hopkins University · R01 · FY2024 · DK

Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers

$377,434
Li Zheng · Beckman Research Institute/City Of Hope · R50 · FY2022 · CA

Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers

$377,434
Li Zheng · Beckman Research Institute/City Of Hope · R50 · FY2025 · CA

Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers

$377,434
Li Zheng · Beckman Research Institute/City Of Hope · R50 · FY2021 · CA

Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers

$377,434
Li Zheng · Beckman Research Institute/City Of Hope · R50 · FY2024 · CA

Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers

$377,434
Li Zheng · Beckman Research Institute/City Of Hope · R50 · FY2023 · CA

Project 2: Dual Targeting of B7-H3 in mCRPC

$377,386
Kenneth J. Pienta · Johns Hopkins University · P50 · FY2025 · CA

Glucocorticoids & Vitamin D: Role in Antitumor Effects

$377,384
Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA

Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium

$377,353
Cory Abate-Shen · Columbia University Health Sciences · U01 · FY2013 · CA

Molecular Link Between Metabolic Syndrome and Prostate Cancer

$377,253
Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Molecular Link Between Metabolic Syndrome and Prostate Cancer

$377,253
Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2016 · CA

Therapeutic targeting Wnt5A signaling for advanced prostate cancer

$377,221
Allen C Gao · University Of California At Davis · R01 · FY2022 · CA

Molecular Link Between Metabolic Syndrome and Prostate Cancer

$377,216
Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2014 · CA